Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes

BACKGROUND: Fibroblast growth factor 21 (FGF21), a glucose and lipid metabolic regulator, has recently been demonstrated to be associated with cardiovascular diseases (CVD) such as carotid atherosclerosis, coronary heart disease and carotid artery plaques. However, the relationship between circulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yang, Liu, Lingjiao, Xu, Aimin, Zhou, Pengcheng, Long, Zhaofeng, Tu, Yiting, Chen, Xiaoyan, Tang, Weili, Huang, Gan, Zhou, Zhiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475300/
https://www.ncbi.nlm.nih.gov/pubmed/26047614
http://dx.doi.org/10.1186/s12933-015-0229-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475300/
https://www.ncbi.nlm.nih.gov/pubmed/26047614
http://dx.doi.org/10.1186/s12933-015-0229-9

Ejemplares similares